![Michael Landsittel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Landsittel
Direktör/Styrelseledamot på
DAMORA THERAPEUTICS, INC.
Profil
Michael Landsittel is currently an Independent Director at Damora Therapeutics, Inc., starting in 2026.
Formerly, Mr. Landsittel was Chief Financial Officer at Blueprint Medicines Corp.
from 2019 to 2025, Senior Director-Finance at Algeta US LLC from 2012 to 2014, and Finance Director at Infinity Pharmaceuticals, Inc. in 2012.
Mr. Landsittel completed undergraduate studies at the University of Michigan in 1994 and earned an MBA from the Tuck School of Business at Dartmouth in 2002.
Aktiva positioner av Michael Landsittel
| Företag | Position | Start |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2026-03-23 |
Tidigare kända positioner av Michael Landsittel
| Företag | Position | Slut |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Finansdirektör/CFO | 2025-11-01 |
Algeta US LLC
 Algeta US LLC Pharmaceuticals: MajorHealth Technology Engages in developing, manufacturing and marketing novel targeted therapies for patients with cancer | Finansdirektör/CFO | 2014-07-01 |
| INFINITY PHARMACEUTICALS, INC. | Företagsledare/Principal | 2012-10-01 |
Michael Landsittels utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
88
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta US LLC
Algeta US LLC Pharmaceuticals: MajorHealth Technology Engages in developing, manufacturing and marketing novel targeted therapies for patients with cancer | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
